Literature DB >> 12021539

Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.

Rafael A Navascués, Ernesto Gómez, Minerva Rodriguez, Ana S Laures, Jose Baltar, Jaime A Grande.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12021539     DOI： 10.1159/000057624

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  3 in total

Review 1.  Gout and organ transplantation.

Authors:  Lisa K Stamp; Peter T Chapman
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 2.  Effects of hyperuricemia on renal function of renal transplant recipients: a systematic review and meta-analysis of cohort studies.

Authors:  Yan Huang; Yu-Lin Li; He Huang; Ling Wang; Wen-Ming Yuan; Jing Li
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

3.  Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial.

Authors:  Nut Koonrungsesomboon; Nuttapong Ngamphaiboon; Natavudh Townamchai; Pimpisa Teeyakasem; Chaiyut Charoentum; Pimlak Charoenkwan; Rungrote Natesirinilkul; Lalita Sathitsamitphong; Touch Ativitavas; Parunya Chaiyawat; Jeerawan Klangjorhor; Suradej Hongeng; Dumnoensun Pruksakorn
Journal:  BMC Cancer       Date:  2020-03-30       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.